Indivior reported 115M in Pre-Tax Profit for its fiscal semester ending in March of 2026.





Pre Tax Profit Change Date
AstraZeneca USD 4.81B 894M Jun/2026
Cassava Sciences USD -10.81M 33.41M Sep/2025
GlaxoSmithKline GBP 2.68B 532M Jun/2026
Glaxosmithkline GBP 2.14B 312M Mar/2026
Hikma Pharmaceutical USD 147.5M 3.5M Jun/2025
Roche Holding CHF 11.17B 6.38B Jun/2026
West Pharmaceutical Services USD 180.1M 18.6M Mar/2026